Other

Net Change in Cash

Revolution Medicines, Inc. Net Change in Cash increased by 131.1% to $57.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 127.3%, from -$209.51M to $57.19M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026

How to read this metric

A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.

Detailed definition

The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...

Peer comparison

A fundamental liquidity metric used to compare cash management efficiency across all public companies.

Metric ID: net_change_in_cash

Historical Data

16 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$156.00M-$66.45M-$10.83M$8.11M$73.16M$265.81M-$46.04M-$22.13M$338.39M-$407.72M-$12.72M-$74.59M-$209.51M$69.10M-$184.05M$57.19M
QoQ Change+57.4%+83.7%+174.9%+801.7%+263.3%-117.3%+51.9%>999%-220.5%+96.9%-486.5%-180.9%+133.0%-366.4%+131.1%
YoY Change+105.2%+210.1%>999%-667.4%-130.3%-253.4%+72.4%-237.0%+48.6%+643.3%-146.7%+127.3%
Range-$407.72M$338.39M
CAGR-23.5%
Avg YoY Growth+193.9%
Median YoY Growth+60.5%

Frequently Asked Questions

What is Revolution Medicines, Inc.'s net change in cash?
Revolution Medicines, Inc. (RVMD) reported net change in cash of $57.19M in Q1 2026.
How has Revolution Medicines, Inc.'s net change in cash changed year-over-year?
Revolution Medicines, Inc.'s net change in cash increased by 127.3% year-over-year, from -$209.51M to $57.19M.
What does net change in cash mean?
The total change in the company's cash position over the period.